Filing Details
- Accession Number:
- 0001437749-13-015656
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-04 17:59:36
- Reporting Period:
- 2013-12-02
- Filing Date:
- 2013-12-04
- Accepted Time:
- 2013-12-04 17:59:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1389545 | Novabay Pharmaceuticals Inc. | NBY | Pharmaceutical Preparations (2834) | 680454536 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1593301 | Pioneer Pharma (Hong Kong) Co Ltd | Flat 2605, 26/F Trendy Centre 682 Castle Peak Road Lai Chi Kok, Kowloon, Hk | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-12-02 | 5,000,000 | $1.14 | 7,005,656 | No | 4 | P | Indirect | By Pioneer Pharma (Singapore) Pte. Ltd. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Pioneer Pharma (Singapore) Pte. Ltd. |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Purchase Warrant (Right to Buy) | Disposition | 2013-12-02 | 800,000 | $0.00 | 800,000 | $1.50 |
Common Stock | Common Stock Purchase Warrant (Right to Buy) | Disposition | 2013-12-02 | 1,200,000 | $0.00 | 1,200,000 | $1.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2012-09-13 | 2013-11-29 | No | 4 | H | Indirect |
0 | 2012-11-01 | 2013-11-29 | No | 4 | H | Indirect |
Footnotes
- The shares and warrants are held by Pioneer Pharma (Singapore) Pte. Ltd., which is a wholly owned subsidiary of the Reporting Person.